InsidersTradesSigma
Discover the full insider trade history of 경보제약, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 경보제약 has recorded 1 public disclosures. Market capitalisation: €143.7bn. The latest transaction was filed on 5 March 2026 — Purchase. Among the most active insiders: 정희록. The full history is free.
FY ended December 2025 · cache
0 of 0 declarations